Evaluation of Point-of-Care-Directed Coagulation Management in Pediatric Cardiac Surgery

被引:0
作者
Zajonz, Thomas [1 ]
Edinger, Fabian [1 ]
Hofmann, Johannes [1 ]
Yoerueker, Uygar [2 ]
Akintuerk, Hakan [2 ]
Markmann, Melanie [1 ]
Mueller, Matthias [1 ]
机构
[1] Justus Liebig Univ, Dept Anesthesiol Operat Intens Care & Pain Med, Giessen Fachbereich Med, Rudolf Buchheim Str 7, D-35392 Giessen, Hessen, Germany
[2] Justus Liebig Univ, Childrens Heart Ctr & Cardiovasc Surg, Giessen Fachbereich Med, Giessen, Hessen, Germany
关键词
transfusion; blood; cardiopulmonary bypass; CPB; pediatric; surgery; complications; ACTIVATED CLOTTING TIME; BLOOD-PRODUCT UTILIZATION; CARDIOPULMONARY BYPASS; HEMOSTATIC SYSTEM; DOSE HEPARIN; HEPCON HMS; THROMBOELASTOMETRY; TRANSFUSION; CHILDREN; FIBRINOGEN;
D O I
10.1055/s-0044-1788931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Coagulatory alterations are common after pediatric cardiac surgery and can be addressed with point-of-care (POC) coagulation analysis. The aim of the present study is to evaluate a preventive POC-controlled coagulation algorithm in pediatric cardiac surgery. Methods This single-center, retrospective data analysis included patients younger than 18 years who underwent cardiac surgery with cardiopulmonary bypass (CPB) and received a coagulation therapy according to a predefined POC-controlled coagulation algorithm. Patients were divided into two groups (<10 and >10 kg body weight) because of different CPB priming strategies. Results In total, 173 surgeries with the use of the POC-guided hemostatic therapy were analyzed. In 71% of cases, target parameters were achieved and only in one case primary sternal closure was not possible. Children with a body weight <= 10 kg underwent surgical re-evaluation in 13.2% (15/113), and respectively 6.7% (4/60) in patients >10 kg. Hemorrhage in children <= 10 kg was associated with cyanotic heart defects, deeper intraoperative hypothermia, longer duration of CPB, more complex procedures (RACHS-1 score), and with more intraoperative platelets, and respectively red blood cell concentrate transfusions (all p- values < 0.05). In children <= 10 kg, fibrinogen levels were significantly lower over the 12-hour postoperative period (without revision: 3.1 [2.9-3.3] vs. with revision 2.8 [2.3-3.4]). Hemorrhage in children >10 kg was associated with a longer duration of CPB ( p = 0.042), lower preoperative platelets ( p = 0.026), and over the 12-hour postoperative period lower platelets ( p = 0.002) and fibrinogen ( p = 0.05). Conclusion The use of a preventive, algorithm-based coagulation therapy with factor concentrates after CPB followed by POC created intraoperative clinical stable coagulation status with a subsequent executable thorax closure, although the presented algorithm in its current form is not superior in the reduction of the re-exploration rate compared to equivalent collectives. Reduced fibrinogen concentrations 12 hours after surgery may be associated with an increased incidence of surgical revisions.
引用
收藏
页码:387 / 400
页数:14
相关论文
共 82 条
[1]   Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery [J].
Abuelkasem, Ezeldeen ;
Mazzeffi, Michael A. ;
Henderson, Reney A. ;
Wipfli, Camron ;
Monroe, Angie ;
Strauss, Erik R. ;
Chow, Jonathan H. ;
Tanaka, Kenichi A. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2019, 33 (08) :2153-2160
[2]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[3]   Validation of a definition of excessive postoperative bleeding in infants undergoing cardiac surgery with cardiopulmonary bypass [J].
Bercovitz, Rachel S. ;
Shewmake, Allison C. ;
Newman, Debra K. ;
Niebler, Robert A. ;
Scott, John P. ;
Stuth, Eckehard ;
Simpson, Pippa M. ;
Yan, Ke ;
Woods, Ronald K. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (05) :2112-+
[4]   Use of Coagulation Point-of-Care Tests in the Management of Anticoagulation and Bleeding in Pediatric Cardiac Surgery: A Systematic Review [J].
Bianchi, Paolo ;
Beccaris, Camilla ;
Norbert, Martina ;
Dunlop, Bradley ;
Ranucci, Marco .
ANESTHESIA AND ANALGESIA, 2020, 130 (06) :1594-1604
[5]   Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model [J].
Bolliger, D. ;
Szlam, F. ;
Molinaro, R. J. ;
Rahe-Meyer, N. ;
Levy, J. H. ;
Tanaka, K. A. .
BRITISH JOURNAL OF ANAESTHESIA, 2009, 102 (06) :793-799
[6]   Toward Optimal Anticoagulation Monitoring During Cardiopulmonary Bypass: It Is Still A Tough "ACT" [J].
Bolliger, Daniel ;
Maurer, Markus ;
Tanaka, Kenichi A. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (11) :2928-2930
[7]   Fibrin Network Changes in Neonates after Cardiopulmonary Bypass [J].
Brown, Ashley C. ;
Hannan, Riley H. ;
Timmins, Lucas H. ;
Fernandez, Janet D. ;
Barker, Thomas H. ;
Guzzetta, Nina A. .
ANESTHESIOLOGY, 2016, 124 (05) :1021-1031
[8]  
Chan AKC, 1997, THROMB HAEMOSTASIS, V77, P270
[9]   Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass [J].
Chandler, WL ;
Velan, T .
THROMBOSIS RESEARCH, 2003, 112 (03) :185-192
[10]   Observational Safety Study of Clottafact® Fibrinogen Concentrate: Real-World Data in Mexico [J].
Colin-Bracamontes, Ignacio ;
Perez-Calatayud, Angel Augusto ;
Carrillo-Esper, Raul ;
Rodriguez-Ayala, Ernesto ;
Padilla-Molina, Misael ;
Posadas-Nava, Alejandro ;
Olvera-Vazquez, Susana ;
Hernandez-Salgado, Lidia .
CLINICAL DRUG INVESTIGATION, 2020, 40 (05) :485-491